US Stock MarketDetailed Quotes

LIFE aTyr Pharma

Watchlist
  • 1.590
  • -0.010-0.63%
Trading Apr 30 10:31 ET
108.03MMarket Cap-1691P/E (TTM)

aTyr Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-96.60%353K
0
353K
0
0
10.39M
10.39M
0
0
0
Operating revenue
-96.60%353K
--0
--353K
--0
--0
--10.39M
--10.39M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-2.67%55.27M
-12.96%15.96M
-3.88%12.97M
7.74%13.56M
3.30%12.79M
66.96%56.79M
112.22%18.34M
74.59%13.49M
20.48%12.58M
71.87%12.38M
Selling and administrative expenses
-7.17%12.98M
-6.48%3.2M
-26.92%2.65M
7.80%3.72M
-2.13%3.41M
30.05%13.98M
27.60%3.43M
39.96%3.63M
23.62%3.45M
29.64%3.48M
-General and administrative expense
-7.17%12.98M
-6.48%3.2M
-26.92%2.65M
7.80%3.72M
-2.13%3.41M
30.05%13.98M
27.60%3.43M
39.96%3.63M
23.62%3.45M
29.64%3.48M
Research and development costs
-1.20%42.29M
-14.45%12.76M
4.58%10.32M
7.72%9.84M
5.43%9.38M
84.01%42.81M
150.38%14.91M
92.04%9.87M
19.33%9.14M
96.99%8.9M
Operating profit
-18.35%-54.92M
-100.74%-15.96M
6.50%-12.62M
-7.74%-13.56M
-3.30%-12.79M
-36.42%-46.4M
7.99%-7.95M
-74.59%-13.49M
-20.48%-12.58M
-71.87%-12.38M
Net non-operating interest income expense
Other net income (expense)
326.20%4.52M
180.56%1.2M
415.38%1.27M
646.01%1.22M
272.77%835K
345.80%1.06M
440.51%427K
318.64%247K
207.55%163K
376.60%224K
Other non- operating income (expenses)
326.20%4.52M
180.56%1.2M
415.38%1.27M
646.01%1.22M
272.77%835K
345.80%1.06M
440.51%427K
318.64%247K
207.55%163K
376.60%224K
Income before tax
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
-19.52%-12.42M
-69.87%-12.15M
Income tax
Net income
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
-19.52%-12.42M
-69.87%-12.15M
Net income continuous Operations
-11.15%-50.4M
-96.21%-14.76M
14.37%-11.34M
0.64%-12.34M
1.66%-11.95M
-34.24%-45.34M
12.12%-7.52M
-72.71%-13.25M
-19.52%-12.42M
-69.87%-12.15M
Minority interest income
-60.00%-8K
50.00%-1K
-100.00%-2K
-300.00%-4K
0.00%-1K
44.44%-5K
0.00%-2K
50.00%-1K
0.00%-1K
75.00%-1K
Net income attributable to the parent company
-11.14%-50.39M
-96.25%-14.76M
14.38%-11.34M
0.66%-12.34M
1.66%-11.95M
-34.26%-45.34M
12.13%-7.52M
-72.74%-13.24M
-19.53%-12.42M
-69.95%-12.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.14%-50.39M
-96.25%-14.76M
14.38%-11.34M
0.66%-12.34M
1.66%-11.95M
-34.26%-45.34M
12.13%-7.52M
-72.74%-13.24M
-19.53%-12.42M
-69.95%-12.15M
Basic earnings per share
41.25%-0.94
3.85%-0.25
56.52%-0.2
50.00%-0.22
34.09%-0.29
9.60%-1.6
16.13%-0.26
-9.52%-0.46
31.25%-0.44
13.73%-0.44
Diluted earnings per share
41.25%-0.94
3.85%-0.25
56.52%-0.2
50.00%-0.22
34.09%-0.29
9.60%-1.6
16.13%-0.26
-9.52%-0.46
31.25%-0.44
13.73%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -96.60%353K0353K0010.39M10.39M000
Operating revenue -96.60%353K--0--353K--0--0--10.39M--10.39M--0--0--0
Cost of revenue
Gross profit
Operating expense -2.67%55.27M-12.96%15.96M-3.88%12.97M7.74%13.56M3.30%12.79M66.96%56.79M112.22%18.34M74.59%13.49M20.48%12.58M71.87%12.38M
Selling and administrative expenses -7.17%12.98M-6.48%3.2M-26.92%2.65M7.80%3.72M-2.13%3.41M30.05%13.98M27.60%3.43M39.96%3.63M23.62%3.45M29.64%3.48M
-General and administrative expense -7.17%12.98M-6.48%3.2M-26.92%2.65M7.80%3.72M-2.13%3.41M30.05%13.98M27.60%3.43M39.96%3.63M23.62%3.45M29.64%3.48M
Research and development costs -1.20%42.29M-14.45%12.76M4.58%10.32M7.72%9.84M5.43%9.38M84.01%42.81M150.38%14.91M92.04%9.87M19.33%9.14M96.99%8.9M
Operating profit -18.35%-54.92M-100.74%-15.96M6.50%-12.62M-7.74%-13.56M-3.30%-12.79M-36.42%-46.4M7.99%-7.95M-74.59%-13.49M-20.48%-12.58M-71.87%-12.38M
Net non-operating interest income expense
Other net income (expense) 326.20%4.52M180.56%1.2M415.38%1.27M646.01%1.22M272.77%835K345.80%1.06M440.51%427K318.64%247K207.55%163K376.60%224K
Other non- operating income (expenses) 326.20%4.52M180.56%1.2M415.38%1.27M646.01%1.22M272.77%835K345.80%1.06M440.51%427K318.64%247K207.55%163K376.60%224K
Income before tax -11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M-19.52%-12.42M-69.87%-12.15M
Income tax
Net income -11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M-19.52%-12.42M-69.87%-12.15M
Net income continuous Operations -11.15%-50.4M-96.21%-14.76M14.37%-11.34M0.64%-12.34M1.66%-11.95M-34.24%-45.34M12.12%-7.52M-72.71%-13.25M-19.52%-12.42M-69.87%-12.15M
Minority interest income -60.00%-8K50.00%-1K-100.00%-2K-300.00%-4K0.00%-1K44.44%-5K0.00%-2K50.00%-1K0.00%-1K75.00%-1K
Net income attributable to the parent company -11.14%-50.39M-96.25%-14.76M14.38%-11.34M0.66%-12.34M1.66%-11.95M-34.26%-45.34M12.13%-7.52M-72.74%-13.24M-19.53%-12.42M-69.95%-12.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.14%-50.39M-96.25%-14.76M14.38%-11.34M0.66%-12.34M1.66%-11.95M-34.26%-45.34M12.13%-7.52M-72.74%-13.24M-19.53%-12.42M-69.95%-12.15M
Basic earnings per share 41.25%-0.943.85%-0.2556.52%-0.250.00%-0.2234.09%-0.299.60%-1.616.13%-0.26-9.52%-0.4631.25%-0.4413.73%-0.44
Diluted earnings per share 41.25%-0.943.85%-0.2556.52%-0.250.00%-0.2234.09%-0.299.60%-1.616.13%-0.26-9.52%-0.4631.25%-0.4413.73%-0.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg